Cryo Cell International (CCEL) Other Operating Expenses (2010 - 2026)

Cryo Cell International has disclosed Other Operating Expenses across 17 years of filings, most recently posting $1.8 million for Q1 2026.

• In Q1 2026, Other Operating Expenses fell 15.44% year-over-year to $1.8 million; the TTM figure through Feb 2026 stood at $12.2 million (up 39.31% YoY), while the FY2025 annual figure was $11.6 million, up 34.1% from the prior year.
• Other Operating Expenses fell to $1.8 million in Q1 2026, from $6.3 million in the prior quarter.
• Over the last five years, Other Operating Expenses for CCEL reached as high as $18.2 million in Q4 2023 and fell as low as $1.8 million in Q4 2024.
• The 5-year median for Other Operating Expenses is $2.3 million (2024), against an average of $3.4 million.
• Annual changes were most pronounced in 2023 — Other Operating Expenses surged 600.25% — and 2024, when it plunged 89.91%.
• A 5-year view of Other Operating Expenses shows it stood at $2.6 million in 2022, then surged by 600.25% to $18.2 million in 2023, then sank by 89.91% to $1.8 million in 2024, then soared by 242.49% to $6.3 million in 2025, then tumbled by 70.68% to $1.8 million in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $1.8 million, $6.3 million, and $2.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.